Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trebananib with Pemetrexed and Carboplatin in NSCLC
NCT01666977Phase 2Completed
- Sponsor
- Amgen
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Peptides, Antibody-Based Therapeutics, Fc-Fusion Proteins
- Countries
- 6
01
Overview
A Phase 2 trial of trebananib in non-squamous non-small cell lung cancer, sponsored by Amgen. Started Aug 2012; status: completed.
02
Drugs
trebananib
03
Conditions
non-squamous non-small cell lung cancer
Beyond the preview
Go deeper on NCT01666977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666977.